181 related articles for article (PubMed ID: 7734344)
1. Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major.
Cazzola M; De Stefano P; Ponchio L; Locatelli F; Beguin Y; Dessi C; Barella S; Cao A; Galanello R
Br J Haematol; 1995 Mar; 89(3):473-8. PubMed ID: 7734344
[TBL] [Abstract][Full Text] [Related]
2. A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis.
Cazzola M; Borgna-Pignatti C; Locatelli F; Ponchio L; Beguin Y; De Stefano P
Transfusion; 1997 Feb; 37(2):135-40. PubMed ID: 9051086
[TBL] [Abstract][Full Text] [Related]
3. Serum transferrin receptor as a marker of erythropoiesis suppression in patients on chronic transfusion.
Tancabelic J; Sheth S; Paik M; Piomelli S
Am J Hematol; 1999 Feb; 60(2):121-5. PubMed ID: 9929103
[TBL] [Abstract][Full Text] [Related]
4. Soluble transferrin receptor in beta-thalassaemia.
Musto P; Lombardi G; Centra M; Modoni S; Carotenuto M; Di Giorgio G
Lancet; 1993 Oct; 342(8878):1058. PubMed ID: 8105293
[No Abstract] [Full Text] [Related]
5. Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis.
Cazzola M; Ponchio L; de Benedetti F; Ravelli A; Rosti V; Beguin Y; Invernizzi R; Barosi G; Martini A
Blood; 1996 Jun; 87(11):4824-30. PubMed ID: 8639855
[TBL] [Abstract][Full Text] [Related]
6. Marked increase in serum transferrin receptor among Thai children with Hb-E-beta-thalassaemia.
Boonchalermvichian C; Paritpokee N; Bhokaisawan N; Nuchprayoon I; Wiwanitkit V
J Paediatr Child Health; 2002 Dec; 38(6):601-3. PubMed ID: 12410875
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of serum soluble transferrin receptors and erythropoietin levels as indicators for erythropoietic activity among multi-transfused beta-thalassemic patients.
El-Nawawy A; Massoud MN; El-Bordiny M; Hegazya S
J Trop Pediatr; 2002 Feb; 48(1):33-8. PubMed ID: 11866334
[TBL] [Abstract][Full Text] [Related]
8. Serum erythropoietin and erythropoiesis in high- and low-fetal hemoglobin beta-thalassemia intermedia patients.
Galanello R; Barella S; Turco MP; Giagu N; Cao A; Dore F; Liberato NL; Guarnone R; Barosi G
Blood; 1994 Jan; 83(2):561-5. PubMed ID: 7506955
[TBL] [Abstract][Full Text] [Related]
9. The effect of erythroferrone suppression by transfusion on the erythropoietin-erythroferrone-hepcidin axis in transfusion-dependent thalassaemia: A pre-post cohort study.
Zaman BA; Rasool SO; Abdo JM
Br J Haematol; 2023 May; 201(3):547-551. PubMed ID: 36535905
[TBL] [Abstract][Full Text] [Related]
10. Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β-thalassemia major: a longitudinal study.
Pasricha SR; Frazer DM; Bowden DK; Anderson GJ
Blood; 2013 Jul; 122(1):124-33. PubMed ID: 23656728
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the supertransfusion regimen in homozygous beta-thalassaemia children.
Masera G; Terzoli S; Avanzini A; Fontanelli G; Mauri RA; Piacentini G; Ferrari M
Br J Haematol; 1982 Sep; 52(1):111-3. PubMed ID: 7115620
[TBL] [Abstract][Full Text] [Related]
12. Sustained increase in haemoglobin and RBC following long-term administration of recombinant human erythropoietin to patients with homozygous beta-thalassaemia.
Rachmilewitz EA; Aker M; Perry D; Dover G
Br J Haematol; 1995 Jun; 90(2):341-5. PubMed ID: 7794754
[TBL] [Abstract][Full Text] [Related]
13. Number and maturation of reticulocytes in various genotypes of thalassaemia as assessed by flow cytometry.
Khuhapinant A; Bunyaratvej A; Tatsumi N; Pribwai M; Fucharoen S
Acta Haematol; 1994; 91(3):119-25. PubMed ID: 8091932
[TBL] [Abstract][Full Text] [Related]
14. Fetal haemoglobin augmentation in E/beta(0) thalassaemia: clinical and haematological outcome.
Singer ST; Kuypers FA; Olivieri NF; Weatherall DJ; Mignacca R; Coates TD; Davies S; Sweeters N; Vichinsky EP;
Br J Haematol; 2005 Nov; 131(3):378-88. PubMed ID: 16225658
[TBL] [Abstract][Full Text] [Related]
15. Increased CD177 (PRV1) expression in thalassaemia and the underlying erythropoietic activity.
Zoi K; Terpos E; Zoi C; Loukopoulos D
Br J Haematol; 2008 Apr; 141(1):100-4. PubMed ID: 18324972
[TBL] [Abstract][Full Text] [Related]
16. Correlation between transfusion requirement, blood volume and haemoglobin level in homozygous beta-thalassaemia.
Gabutti V; Piga A; Fortina P; Miniero R; Nicola P
Acta Haematol; 1980; 64(2):103-8. PubMed ID: 6776764
[TBL] [Abstract][Full Text] [Related]
17. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
Porter JB; Cappellini MD; Kattamis A; Viprakasit V; Musallam KM; Zhu Z; Taher AT
Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462
[TBL] [Abstract][Full Text] [Related]
18. Red blood cell precursor mass as an independent determinant of serum erythropoietin level.
Cazzola M; Guarnone R; Cerani P; Centenara E; Rovati A; Beguin Y
Blood; 1998 Mar; 91(6):2139-45. PubMed ID: 9490701
[TBL] [Abstract][Full Text] [Related]
19. Estimation of effective and total erythropoiesis in myelodysplasia using serum transferrin receptor and erythropoietin concentrations, with automated reticulocyte parameters.
Bowen DT; Culligan D; Beguin Y; Kendall R; Willis N
Leukemia; 1994 Jan; 8(1):151-5. PubMed ID: 8289479
[TBL] [Abstract][Full Text] [Related]
20. Genetic determinants related to pharmacological induction of foetal haemoglobin in transfusion-dependent HbE-β thalassaemia.
Biswas S; Nag A; Ghosh K; Ray R; Roy K; Bandyopadhyay A; Bhattacharyya M
Ann Hematol; 2019 Feb; 98(2):289-299. PubMed ID: 30413899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
